paromomycin has been researched along with Canine Diseases in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (9.09) | 18.7374 |
1990's | 5 (45.45) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (27.27) | 24.3611 |
2020's | 2 (18.18) | 2.80 |
Authors | Studies |
---|---|
Coelho, AC; Coser, EM; Cotrim, PC; da L Oliveira, V; Ferreira, BA; Martins, TFC; Pinto, MM; Rocha, MC; Yamashiro-Kanashiro, EH | 1 |
Apostolidis, K; Buono, A; Chatzis, MK; Kasabalis, D; Leontides, LS; Petanides, T; Polizopoulou, ZS; Saridomichelakis, MN; Steiner, JM; Suchodolski, JS; Xenoulis, PG | 1 |
Apostolidis, K; Athanasiou, LV; Chatzis, MK; Ikonomopoulos, J; Kasabalis, D; Leontides, LS; Mataragka, A; Petanides, T; Saridomichelakis, MN; Xenoulis, PG | 1 |
Athanasiou, LV; Batzias, GC; Delis, G; Kontos, VI; Rallis, TS; Saridomichelakis, MN; Soubasis, N | 1 |
Athanasiou, LV; Kontos, VI; Rallis, TS; Saridomichelakis, MN; Spanakos, G | 1 |
Belloli, C; Carli, S; Ceci, L; De Natale, G; Marcotrigiano, G; Montesissa, C; Ormas, P; Tassi, P | 1 |
Bandinelli, P; Guidi, G; Mancianti, F; Poli, A; Sozzi, S | 1 |
Cavalcante, R; Fonseca de Castro, JA; Furtado Campos, JH; Miles, MA; Olliaro, PL; Tavares, JP; Vexenat, JA | 1 |
Ciaramella, P; Cortese, L; de Luna, R; Gradoni, L; Oliva, G; Orsini, S; Persechino, A; Scalone, A | 1 |
Belloli, C; Bertini, S; Carli, S; Crescenzo, G; Mengozzi, G; Ormas, P; Zaghini, A | 1 |
Ulivelli, A | 1 |
4 trial(s) available for paromomycin and Canine Diseases
Article | Year |
---|---|
Evaluation of nephrotoxicity and ototoxicity of aminosidine (paromomycin)-allopurinol combination in dogs with leishmaniosis due to Leishmania infantum: A randomized, blinded, controlled study.
Topics: Allopurinol; Animals; Cochlea; Creatinine; Dog Diseases; Dogs; Double-Blind Method; Drug Combinations; Evoked Potentials, Auditory, Brain Stem; Female; Hearing; Hearing Loss; Injections, Subcutaneous; Kidney; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine Antimoniate; Neurologic Examination; Paromomycin; Random Allocation; Vestibule, Labyrinth | 2019 |
A randomized, blinded, controlled clinical trial comparing the efficacy of aminosidine (paromomycin)-allopurinol combination with the efficacy of meglumine antimoniate-allopurinol combination for the treatment of canine leishmaniosis due to Leishmania inf
Topics: Allopurinol; Animals; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Injections, Subcutaneous; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine Antimoniate; Paromomycin; Trypanocidal Agents | 2020 |
Treatment of canine leishmaniosis with aminosidine at an optimized dosage regimen: a pilot open clinical trial.
Topics: Animals; Antibodies, Protozoan; Antiprotozoal Agents; Bone Marrow; DNA, Protozoan; Dog Diseases; Dogs; Drug Dosage Calculations; Female; Fluorescent Antibody Technique, Indirect; Injections, Subcutaneous; Leishmania infantum; Leishmaniasis, Visceral; Lymph Nodes; Male; Paromomycin; Pilot Projects; Polymerase Chain Reaction; Treatment Outcome | 2013 |
Comparison of aminosidine (paromomycin) and sodium stibogluconate for treatment of canine leishmaniasis.
Topics: Amebicides; Animals; Antibodies, Protozoan; Antigen-Antibody Complex; Antigens, Protozoan; Antimony Sodium Gluconate; Antiprotozoal Agents; Dog Diseases; Dogs; Female; Immunoglobulin G; Leishmania infantum; Leishmaniasis, Visceral; Male; Paromomycin; Proteinuria; Time Factors | 1997 |
7 other study(ies) available for paromomycin and Canine Diseases
Article | Year |
---|---|
Isolation, typing, and drug susceptibility of Leishmania (Leishmania) infantum isolates from dogs of the municipality of Embu das Artes, an endemic region for canine leishmaniasis in Brazil.
Topics: Animals; Brazil; Dog Diseases; Dogs; Humans; Leishmania infantum; Leishmaniasis, Visceral; Paromomycin | 2022 |
Pharmacokinetics and tolerability of aminosidine after repeated administrations using an optimal dose regimen in healthy dogs and in dogs with leishmaniosis.
Topics: Animals; Chromatography, High Pressure Liquid; Dog Diseases; Dogs; Drug Administration Schedule; Female; Half-Life; Injections, Subcutaneous; Leishmania; Leishmaniasis; Male; Paromomycin | 2014 |
Disposition of antimony and aminosidine in dogs after administration separately and together: implications for therapy of leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Interactions; Female; Injections, Subcutaneous; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Models, Biological; Organometallic Compounds; Paromomycin | 1995 |
Clinical recovery and limited cure in canine visceral leishmaniasis treated with aminosidine (paromomycin).
Topics: Animals; Antiprotozoal Agents; Disease Reservoirs; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Leishmaniasis, Visceral; Paromomycin; Recurrence; Treatment Outcome | 1998 |
Comparative efficacy of meglumine antimoniate and aminosidine sulphate, alone or in combination, in canine leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Paromomycin; Treatment Outcome | 1998 |
Disposition of antimony and aminosidine combination after multiple subcutaneous injections in dogs.
Topics: Amebicides; Animals; Antimony; Antiprotozoal Agents; Area Under Curve; Chromatography, Liquid; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Fluorometry; Half-Life; Injections, Subcutaneous; Least-Squares Analysis; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Paromomycin; Spectrophotometry, Atomic | 1999 |
[A propos of antibiotic therapy (with paromomycin) in some cestode infections].
Topics: Adolescent; Adult; Animals; Cestode Infections; Child; Child, Preschool; Dog Diseases; Dogs; Humans; Infant; Middle Aged; Paromomycin | 1967 |